Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 11, 2024
Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 04, 2013
Showing 1-2 of 2
Last Updated: 09/26/2026